Caspase-2 (Casp2) is a promising therapeutic target in several human diseases, including nonalcoholic steatohepatitis (NASH) and Alzheimer’s disease (AD). This evidence concerns the gene CASP2 and metabolic dysfunction-associated steatohepatitis.